Phase III at a glance

The Canadian Consortium on Neurodegeneration in Aging (CCNA) is a national network that integrates multiple disciplines and approaches to dementia research. The consortium catalyzes research on the conditions that bring about dementia, seeks new treatments, and explores ways to improve the quality of life of people living with dementia.

CCNA Phase III (2024-2029) includes:

• CCNA Central Operations at Baycrest

• CCNA-affiliated research Teams
  • The funding opportunity for the Teams is open for applications now (application submission deadline: Dec. 11th, 2024)

• Dementia research support hub
  • Training and Capacity Building
  • Women, Sex, Gender, and Dementia
  • Knowledge Mobilization
  • Engagement of People with Lived Experience of Dementia
  • Indigenous Cognitive Health

• Platforms
  • The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) Study
  • The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia
  • LORIS Database
  • Neuroimaging protocol